Resource Center: Drug seeking

Results 1 - 10 of 13

Search Results

Complete Text of the US Code, Title 21
Description: 
This is the full text of Title 21, Chapter 13 of the US Code, which deals with drug abuse prevention and control.
Source: 
Drug Enforcement Administration (DEA)
4.333335
Your rating: None Average: 4.3 (3 votes)
Tags:
Identification and Management of the Drug-Seeking Patient
Description: 
This article describes how to identify drug-seeking patients, and explains risk management measures.
Source: 
American Family Physician, 2000
4.333335
Your rating: None Average: 4.3 (3 votes)
Tags:
Adherence, Diversion and Misuse of Sublingual Buprenorphine
Description: 
This 2010 Physician Clinical Support System (PCSS) document written by Dr. Judith Martin discusses types of aberrant behavior associated with buprenorphine and steps that can be taken to reduce the risk of abuse and diversion.
Source: 
Physician Clinical Support System (PCSS)
0
Your rating: None
Tags:
RADARS® System
Description: 
RADARS®, the Researched Abuse, Diversion, and Addiction-Related Surveillance System, tracks prescription drug abuse, misuse and diversion throughout the United States. It is a nonprofit operation of the Rocky Mountain Poison and Drug Center, a division of Denver Health.
Source: 
RADARS®
4.333335
Your rating: None Average: 4.3 (3 votes)
Tags:
Spotting Drug-Seeking Patients
Description: 
Article describing eight different ways to identify and help drug-seeking patients in your practice.
Source: 
Medical Economics
3.333335
Your rating: None Average: 3.3 (3 votes)
Tags:

Mistaking Legitimate Users for Drug Misusers

Description: 
Situations in which legitimate narcotic users can be misidentified as drug misusers.

There are several situations in which legitimate narcotics users can be misidentified as drug misusers, including the following:

0
Your rating: None
Tags:
DEA Policy Statement: Dispensing Controlled Substances for the Treatment of Pain
Description: 
This 2006 document explains the Drug Enforcement Agency's (DEA) role in regulation of controlled substances and the physician's legal responsibility to prescribe controlled substances for legitimate medical purposes.
Source: 
Drug Enforcement Agency (DEA)
4.333335
Your rating: None Average: 4.3 (3 votes)
Tags:
A Closer Look at State Prescription Monitoring Programs (DEA FAQ's)
Description: 
These FAQs address common questions regarding prescription drug monitoring programs.
Source: 
Drug Enforcement Agency (DEA)
4
Your rating: None Average: 4 (4 votes)
Tags:
Emerging Clinical Challenges in Prescribing Buprenorphine
Description: 
This presentation examines issues that have arisen in buprenorphine treatment to date and suggests measures that can be taken to address these issues going forward.
Source: 
Elinore McCance-Katz, M.D., Ph.D. (presentation from SAMHSA 2008 Buprenorphine Summit)
4.5
Your rating: None Average: 4.5 (2 votes)
Tags:
Practitioner's Manual: An Informational Outline of the Controlled Substances Act
Description: 
Manual written by the DEA to assist physicians in understanding and complying with the Federal Controlled Substances Act. Topics covered include recordkeeping requirements, rules regarding prescription, and security requirements.
Source: 
US Drug Enforcement Administration (DEA)
4.666665
Your rating: None Average: 4.7 (3 votes)
Tags: